Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
20 May 2024
|
m 17:14 | Mantle cell lymphoma 3 changes history +757 [Jwarner (3×)] | |||
m |
|
17:14 (cur | prev) +9 Jwarner talk contribs →Rituximab monotherapy {{#subobject:712b01|Regimen=1}} | |||
m |
|
17:10 (cur | prev) +178 Jwarner talk contribs →Regimen variant #4, 18 doses {{#subobject:572f85|Variant=1}} | |||
m |
|
17:08 (cur | prev) +570 Jwarner talk contribs →References |
19 May 2024
m 00:38 | Mantle cell lymphoma diffhist +17 Jwarner talk contribs →Brexucabtagene autoleucel monotherapy {{#subobject:4z3u14|Regimen=1}} |
16 May 2024
m 00:00 | Mantle cell lymphoma diffhist -33 Jwarner talk contribs →First-line therapy, non-randomized or retrospective data |
10 May 2024
m 20:25 | Peripheral T-cell lymphoma diffhist +905 Jwarner talk contribs →CHOP {{#subobject:38ee4a|Regimen=1}} |
9 May 2024
|
m 02:38 | Peripheral T-cell lymphoma 2 changes history +5 [Warner-admin (2×)] | |||
m |
|
02:38 (cur | prev) -16 Warner-admin talk contribs Text replacement - "https://www.nccn.org/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1483" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1483" | |||
m |
|
02:13 (cur | prev) +21 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/t-cell.pdf" to "https://www.nccn.org/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1483" |